These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27598902)

  • 21. Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats.
    Cha DR; Kang YS; Han SY; Jee YH; Han KH; Han JY; Kim YS; Kim NH
    J Endocrinol; 2004 Oct; 183(1):183-94. PubMed ID: 15525586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEGF and the diabetic kidney: More than too much of a good thing.
    Majumder S; Advani A
    J Diabetes Complications; 2017 Jan; 31(1):273-279. PubMed ID: 27836681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of adenosine A2B receptor inhibition on VEGF and nitric oxide axis-mediated renal function in diabetic nephropathy.
    Patel L; Thaker A
    Ren Fail; 2014 Jul; 36(6):916-24. PubMed ID: 24678970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased renal expression of vascular endothelial growth factor in lupus nephritis is associated with worse prognosis.
    Avihingsanon Y; Benjachat T; Tassanarong A; Sodsai P; Kittikovit V; Hirankarn N
    Kidney Int; 2009 Jun; 75(12):1340-1348. PubMed ID: 19295501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes of kidney transplants on patients with end-stage renal disease secondary to lupus nephritis, polycystic kidney disease and diabetic nephropathy.
    Nieto-Ríos JF; Serna-Higuita LM; Builes-Rodriguez SA; Restrepo-Correa RC; Aristizabal-Alzate A; Ocampo-Kohn C; Serna-Campuzano A; Cardona-Díaz N; Giraldo-Ramirez ND; Zuluaga-Valencia GA
    Colomb Med (Cali); 2016 Mar; 47(1):51-8. PubMed ID: 27226665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.
    Schrijvers BF; Flyvbjerg A; Tilton RG; Lameire NH; De Vriese AS
    Nephrol Dial Transplant; 2006 Feb; 21(2):324-9. PubMed ID: 16249198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
    Schrijvers BF; De Vriese AS; Tilton RG; Van de Voorde J; Denner L; Lameire NH; Flyvbjerg A
    Horm Metab Res; 2005 Jan; 37(1):21-5. PubMed ID: 15702434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes.
    Kanetsuna Y; Hirano K; Nagata M; Gannon MA; Takahashi K; Harris RC; Breyer MD; Takahashi T
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1315-22. PubMed ID: 16705146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice.
    Kosugi T; Nakayama T; Li Q; Chiodo VA; Zhang L; Campbell-Thompson M; Grant M; Croker BP; Nakagawa T
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F609-16. PubMed ID: 20015944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression profile of total VEGF, VEGF splice variants and VEGF receptors in the myocardium and arterial vasculature of diabetic and non-diabetic patients with coronary artery disease.
    Zygalaki E; Kaklamanis L; Nikolaou NI; Kyrzopoulos S; Houri M; Kyriakides Z; Lianidou ES; Kremastinos DT
    Clin Biochem; 2008 Jan; 41(1-2):82-7. PubMed ID: 17961532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Over-expression of platelet-derived growth factor in human diabetic nephropathy.
    Langham RG; Kelly DJ; Maguire J; Dowling JP; Gilbert RE; Thomson NM
    Nephrol Dial Transplant; 2003 Jul; 18(7):1392-6. PubMed ID: 12808179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.
    Nam SM; Lee MY; Koh JH; Park JH; Shin JY; Shin YG; Koh SB; Lee EY; Chung CH
    Diabetes Res Clin Pract; 2009 Feb; 83(2):176-82. PubMed ID: 19111363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated image analysis of a glomerular injury marker desmin in spontaneously diabetic Torii rats treated with losartan.
    Kakimoto T; Okada K; Hirohashi Y; Relator R; Kawai M; Iguchi T; Fujitaka K; Nishio M; Kato T; Fukunari A; Utsumi H
    J Endocrinol; 2014 Jul; 222(1):43-51. PubMed ID: 24781258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
    Wang S; Li Y; Huang YJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy.
    Kanesaki Y; Suzuki D; Uehara G; Toyoda M; Katoh T; Sakai H; Watanabe T
    Am J Kidney Dis; 2005 Feb; 45(2):288-94. PubMed ID: 15685506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the TNF pathway in the progression of diabetic nephropathy in KK-A(y) mice.
    Omote K; Gohda T; Murakoshi M; Sasaki Y; Kazuno S; Fujimura T; Ishizaka M; Sonoda Y; Tomino Y
    Am J Physiol Renal Physiol; 2014 Jun; 306(11):F1335-47. PubMed ID: 24647715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Splicing factor polymorphisms, the control of VEGF isoforms and association with angiogenic eye disease.
    Carter JG; Cherry J; Williams K; Turner S; Bates DO; Churchill AJ
    Curr Eye Res; 2011 Apr; 36(4):328-35. PubMed ID: 21309690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
    Ninichuk V; Kulkarni O; Clauss S; Anders H-
    Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The VEGF-A exon 8 splicing-sensitive fluorescent reporter mouse is a novel tool to assess the effects of splicing regulatory compounds
    Stevens M; Star E; Lee M; Innes E; Li L; Bowler E; Harper S; Bates DO; Oltean S
    RNA Biol; 2019 Dec; 16(12):1672-1681. PubMed ID: 31432737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor (VEGF) ligand and receptor induction in rat renal allograft rejection.
    Rintala SE; Savikko J; Rintala JM; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3236-8. PubMed ID: 17175233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.